IP Library Granted Patent US 9,687,242
Granted Patent B2
US 9,687,242 · App. 12/936,110 · Granted Jun 27, 2017

Occlusion device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,687,242
App. No.
12/936,110
Granted
Jun 27, 2017
Kind
B2
Abstract

An occlusion device ( 30 ) includes at least one self-expanding frame ( 42, 44 ) and graft material ( 46 ). Occlusion occurs by constricting the graft material ( 46 ) at a substantially central point or at an end of the device. The constriction is sized such that a guide wire ( 34 ) is able to pass therethrough. A valve mechanism ( 50 ) includes a screen ( 52 ) made from a resilient material and which includes a closable opening ( 54 ). The valve mechanism ( 50 ) allows a guide wire to pass through the occlusion device ( 30 ) while an effective physical barrier is maintained after removal of the guide wire ( 34 ).

Claims (11)

1. An occlusion device for occluding a vessel having an internal wall, the occlusion device comprising:

a frame consisting of a proximal frame and a distal frame for anchoring the device against the internal wall of the vessel to be occluded, the proximal frame being disposed at a proximal end of the occlusion device, the distal frame being at a distal end of the occlusion device, the device having a longitudinal axis therethrough, the proximal frame being longitudinally spaced apart from the distal frame, each of the proximal frame and the distal frame having a tubular metal construction comprising a plurality of struts, each of the proximal frame and the distal frame including a portion for contacting the internal wall of a vessel to be occluded;

at least one occlusion membrane attached to the distal frame at a proximal end of the distal frame and to the proximal frame at a distal end of the proximal frame, the occlusion membrane having a proximal first portion and a distal first portion extending longitudinally for contacting the internal wall of the vessel to be occluded, and a proximal second portion distally adjoining the proximal first portion and a distal second portion proximally adjoining the distal first portion, the proximal and distal second portions directed away from the internal wall of the vessel and toward the longitudinal axis, the occlusion membrane being attached to the frame at least at the proximal and distal first portions, the at least one occlusion membrane radially surrounding at least the proximal end of the distal frame and the distal end of the proximal frame with the proximal and distal first portions, wherein expanding the device within a vessel causes the occlusion membrane to form a physical barrier within a vessel to be occluded, the occlusion membrane having an hourglass shape between the proximal end of the distal frame and the distal end of the proximal frame when expanded; and

a barrier located longitudinally between the distal end of the proximal frame and the proximal end of the distal frame, the barrier extending from the occlusion membrane across a lumen of the device and comprising a closable opening for receiving a guidewire, the barrier comprising a valve biased closed and arranged to not allow blood flow therethrough, the valve comprising leaves which are biased to a closed configuration, the barrier being deformed or relaxed to the closed configuration such that the leaves overlap to form a static screen across the lumen of the device upon removal of the guidewire.

2. The occlusion device of claim 1 wherein the occlusion membrane forms at least one substantially conical portion in the expanded state.

3. The occlusion device of claim 1 wherein the device is bidirectional and wherein the occlusion membrane forms two substantially conical portions in the expanded state.

4. The occlusion device of claim 1 wherein the occlusion membrane is graft material.

5. The occlusion device of claim 1 wherein the occlusion membrane is not fabricated from a bioabsorbable material.

6. The occlusion device of claim 1 wherein the barrier is made of silicone, polyurethane, expanded PTFE, a plastic material, or graft material.

7. The occlusion device of claim 1 wherein the occlusion membrane is attached to the frame internally.

8. The occlusion device of claim 1 wherein the frames are self-expanding.

Assignments (1)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →